TORONTO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Target Group Inc. ("Target" or the "Company") (OTC: CBDY) announced today that after a successful application to up-list from the OTC Pink Market, its Common shares have been upgraded to a listing on the OTCQB ("OTCQB") Venture Market, trading under the ticker symbol "CBDY." "We are very enthusiastic to be upgraded to a listing on the OTCQB Venture Market for early stage and developing U.S. and international companies. This new listing allows U.S. investors the opportunity to further share in the Company's continued expansion and growth internationally," said Rubin Schindermann, CEO and Director of Target. "U.S. investors can obtain Real-Time quotes and market information for the Company at www.otcmarkets.com and access the most current company news and developments."
OTCQB® membership provides enhanced investor benefits, including more stringent reporting standards, increased analyst coverage and access to news services, as well as more comprehensive compliance requirements.
Additionally, Effective September 25, 2018, the Company filed an amended Certificate of Incorporation in Delaware to decrease its authorized common stock from 20,000,000,000 shares to 850,000,000 shares. The Company’s authorized preferred stock remained at 20,000,000 shares.
About Target Group Inc. (OTCQB: CBDY)
Target Group, Inc. is a diversified and vertically integrated progressive company with focus on both national and international presence. The Company operates a wholly-owned late stage Canadian licensed producer regulated under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR): Canary RX, which operates a 44,000 square foot facility located in Norfolk County, Ontario. The Company has begun structuring multiple international production and distribution platforms and intends to continue rapidly expanding its global footprint as it focuses on building an iconic brand portfolio whose focus aims at developing cutting edge Intellectual Property among the medical and recreational cannabis markets. Target Group is committed to building industry-leading companies that transform the perception of cannabis and responsibly elevate the overall consumer experience.
Forward-Looking Statements Disclaimer: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.
Target Group Inc. CEO Rubin Schindermann mob. 647-927-4644 55 Administration Road, Unit 8 Vaughan, Ontario, Canada L4K-4G9